Market closedNon-fractional

Kezar Life Sciences/KZR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Kezar Life Sciences

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Ticker

KZR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

South San Francisco, United States

Employees

58

KZR Metrics

BasicAdvanced
$42M
Market cap
-
P/E ratio
-$1.39
EPS
0.22
Beta
-
Dividend rate
$42M
0.22
11.485
11.314
8.188
10.812
-66.09%
-27.01%
-48.07%
6.012
0.25
0.25
-0.494
31.32%
14.82%

What the Analysts think about KZR

Analyst Ratings

Majority rating from 6 analysts.
Buy

KZR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$0
-100.00%
Net income
-$32M
39.39%
Profit margin
0.00%
-100.00%

KZR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.86%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
-$0.32
-$0.44
-$0.30
-
Expected
-$0.32
-$0.35
-$0.38
-$0.33
-$0.32
Surprise
6.25%
-8.35%
15.85%
-9.86%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kezar Life Sciences stock?

Kezar Life Sciences (KZR) has a market cap of $42M as of July 06, 2024.

What is the P/E ratio for Kezar Life Sciences stock?

The price to earnings (P/E) ratio for Kezar Life Sciences (KZR) stock is 0 as of July 06, 2024.

Does Kezar Life Sciences stock pay dividends?

No, Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Kezar Life Sciences dividend payment date?

Kezar Life Sciences (KZR) stock does not pay dividends to its shareholders.

What is the beta indicator for Kezar Life Sciences?

Kezar Life Sciences (KZR) has a beta rating of 0.22. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Kezar Life Sciences stock

Buy or sell Kezar Life Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing